Combination of TLR1/2 and TLR3 ligands enhances CD4+ T cell longevity and antibody responses by modulating type i IFN production

Bo Ryeong Lee, Soo Kyung Jeong, Byung Cheol Ahn, Byeong Jae Lee, Sung Jae Shin, Jung Sun Yum, Sang Jun Ha

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Despite the possibility of combining Toll-like receptor (TLR) ligands as adjuvants to improve vaccine efficacy, it remains unclear which combinations of TLR ligands are effective or what their underlying mechanisms may be. Here, we investigated the mechanism of action of L-pampo, a proprietary adjuvant composed of TLR1/2 and TLR3 ligands. L-pampo dramatically increased humoral immune responses against the tested target antigens, which was correlated with an increase in follicular helper T cells and the maintenance of antigen-specific CD4+ T cells. During the initial priming phase, in contrast to the induction of type I interferon (IFN) and pro-inflammatory cytokines stimulated by polyI:C, L-pampo showed a greatly diminished induction of type I IFN, but not of other cytokines, and remarkably attenuated IRF3 signaling, which appeared to be critical to L-pampo-mediated adjuvanticity. Collectively, our results demonstrate that the adjuvant L-pampo contributes to the promotion of antigen-specific antibodies and CD4+ T cell responses via a fine regulation of the TLR1/2 and TLR3 signaling pathways, which may be helpful in the design of improved vaccines.

Original languageEnglish
Article number32526
JournalScientific reports
Volume6
DOIs
Publication statusPublished - 2016 Sep 1

Fingerprint

Interferons
Antibody Formation
Interferon Type I
Toll-Like Receptors
Ligands
T-Lymphocytes
Vaccines
Cytokines
Antigens
CD4 Antigens
Humoral Immunity
Helper-Inducer T-Lymphocytes
Maintenance
Antibodies

All Science Journal Classification (ASJC) codes

  • General

Cite this

@article{a19f6764d71b4460be95283343691cae,
title = "Combination of TLR1/2 and TLR3 ligands enhances CD4+ T cell longevity and antibody responses by modulating type i IFN production",
abstract = "Despite the possibility of combining Toll-like receptor (TLR) ligands as adjuvants to improve vaccine efficacy, it remains unclear which combinations of TLR ligands are effective or what their underlying mechanisms may be. Here, we investigated the mechanism of action of L-pampo, a proprietary adjuvant composed of TLR1/2 and TLR3 ligands. L-pampo dramatically increased humoral immune responses against the tested target antigens, which was correlated with an increase in follicular helper T cells and the maintenance of antigen-specific CD4+ T cells. During the initial priming phase, in contrast to the induction of type I interferon (IFN) and pro-inflammatory cytokines stimulated by polyI:C, L-pampo showed a greatly diminished induction of type I IFN, but not of other cytokines, and remarkably attenuated IRF3 signaling, which appeared to be critical to L-pampo-mediated adjuvanticity. Collectively, our results demonstrate that the adjuvant L-pampo contributes to the promotion of antigen-specific antibodies and CD4+ T cell responses via a fine regulation of the TLR1/2 and TLR3 signaling pathways, which may be helpful in the design of improved vaccines.",
author = "Lee, {Bo Ryeong} and Jeong, {Soo Kyung} and Ahn, {Byung Cheol} and Lee, {Byeong Jae} and Shin, {Sung Jae} and Yum, {Jung Sun} and Ha, {Sang Jun}",
year = "2016",
month = "9",
day = "1",
doi = "10.1038/srep32526",
language = "English",
volume = "6",
journal = "Scientific Reports",
issn = "2045-2322",
publisher = "Nature Publishing Group",

}

Combination of TLR1/2 and TLR3 ligands enhances CD4+ T cell longevity and antibody responses by modulating type i IFN production. / Lee, Bo Ryeong; Jeong, Soo Kyung; Ahn, Byung Cheol; Lee, Byeong Jae; Shin, Sung Jae; Yum, Jung Sun; Ha, Sang Jun.

In: Scientific reports, Vol. 6, 32526, 01.09.2016.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Combination of TLR1/2 and TLR3 ligands enhances CD4+ T cell longevity and antibody responses by modulating type i IFN production

AU - Lee, Bo Ryeong

AU - Jeong, Soo Kyung

AU - Ahn, Byung Cheol

AU - Lee, Byeong Jae

AU - Shin, Sung Jae

AU - Yum, Jung Sun

AU - Ha, Sang Jun

PY - 2016/9/1

Y1 - 2016/9/1

N2 - Despite the possibility of combining Toll-like receptor (TLR) ligands as adjuvants to improve vaccine efficacy, it remains unclear which combinations of TLR ligands are effective or what their underlying mechanisms may be. Here, we investigated the mechanism of action of L-pampo, a proprietary adjuvant composed of TLR1/2 and TLR3 ligands. L-pampo dramatically increased humoral immune responses against the tested target antigens, which was correlated with an increase in follicular helper T cells and the maintenance of antigen-specific CD4+ T cells. During the initial priming phase, in contrast to the induction of type I interferon (IFN) and pro-inflammatory cytokines stimulated by polyI:C, L-pampo showed a greatly diminished induction of type I IFN, but not of other cytokines, and remarkably attenuated IRF3 signaling, which appeared to be critical to L-pampo-mediated adjuvanticity. Collectively, our results demonstrate that the adjuvant L-pampo contributes to the promotion of antigen-specific antibodies and CD4+ T cell responses via a fine regulation of the TLR1/2 and TLR3 signaling pathways, which may be helpful in the design of improved vaccines.

AB - Despite the possibility of combining Toll-like receptor (TLR) ligands as adjuvants to improve vaccine efficacy, it remains unclear which combinations of TLR ligands are effective or what their underlying mechanisms may be. Here, we investigated the mechanism of action of L-pampo, a proprietary adjuvant composed of TLR1/2 and TLR3 ligands. L-pampo dramatically increased humoral immune responses against the tested target antigens, which was correlated with an increase in follicular helper T cells and the maintenance of antigen-specific CD4+ T cells. During the initial priming phase, in contrast to the induction of type I interferon (IFN) and pro-inflammatory cytokines stimulated by polyI:C, L-pampo showed a greatly diminished induction of type I IFN, but not of other cytokines, and remarkably attenuated IRF3 signaling, which appeared to be critical to L-pampo-mediated adjuvanticity. Collectively, our results demonstrate that the adjuvant L-pampo contributes to the promotion of antigen-specific antibodies and CD4+ T cell responses via a fine regulation of the TLR1/2 and TLR3 signaling pathways, which may be helpful in the design of improved vaccines.

UR - http://www.scopus.com/inward/record.url?scp=84986220617&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84986220617&partnerID=8YFLogxK

U2 - 10.1038/srep32526

DO - 10.1038/srep32526

M3 - Article

C2 - 27580796

AN - SCOPUS:84986220617

VL - 6

JO - Scientific Reports

JF - Scientific Reports

SN - 2045-2322

M1 - 32526

ER -